AROC · NYSE · STOCK
Archrock (AROC) Stock Analysis
$30.30
52W $22.88 – $42.23
54/100
$5.31B
16.3
0.91
Is AROC Bullish or Bearish?
Mixed.
Innellis AI committee rates Archrock, Inc. (AROC) Watch with a composite score of 54/100
, based on 6 analysts with 50% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +5.79 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -14.21 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case. Risk Analyst remains cautious — high leverage (debt-to-equity 1.62) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 22.0% shows genuine earnings power backing the valuation — Value
- Dividend yield of 4.2% pays you to wait — Value
- EPS growing 40.8% YoY — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- News sentiment is positive (+0.20 across 5 articles, 14d) — News
Bear Case
- Debt-to-equity of 1.62 adds balance-sheet risk to the value case — Value
- 2 consecutive earnings misses -- execution concerns — Growth
- Price structure making lower highs and lower lows — Technical
- Trend and market structure agree -- coherent bearish picture — Technical
- Daily trend (downtrend) conflicts with the weekly trend (uptrend) -- fighting the larger trend — Technical
- High leverage (debt-to-equity 1.62) amplifies downside in a stress scenario — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
54/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 79%
of 93 Energy peers
Value Analyst
neutral
56
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 22.0% shows genuine earnings power backing the valuation
− Debt-to-equity of 1.62 adds balance-sheet risk to the value case
Growth Analyst
bullish
64
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 40.8% YoY
− 2 consecutive earnings misses -- execution concerns
Technical Analyst
neutral
46
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Risk Analyst
bearish
30
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 1.62) amplifies downside in a stress scenario
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
64
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 5 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 54.2 to 54.2.
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
44.9
Neutral
MACD Histogram
0.084
Bullish Momentum
Trend Direction
Downtrend
Weekly: Uptrend
Market Structure
Lh Ll
Support
$23.62
Resistance
$37.68
Bollinger %B
0.33
Inside Bands
Price vs Moving Averages
EMA 9
$30.39
Below
EMA 21
$30.80
Below
EMA 50
$32.08
Below
EMA 200
$32.72
Below
Fundamental Analysis
Valuation
89
Growth
69
Profitability
92
Financial Health
49
Cash Flow
70
Valuation
P/E Ratio
16.3×
P/B Ratio
3.40×
PEG Ratio
0.40
Dividend Yield
2.91%
52W High
$42.23
52W Low
$22.88
Quality & Growth
ROE
2160.9%
ROA
741.0%
Gross Margin
5812.5%
Operating Margin
2701.5%
Revenue Growth YoY
—
Debt / Equity
1.52
AI Fundamental Assessment
P/E ratio of 16.3 (inexpensive relative to a 15-40x range); Price-to-book of 3.4x; PEG ratio of 0.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 21.6%; Return on assets of 7.4%; Net margin of 21.8%; Gross margin of 58.1%; Current ratio of 1.39 (tight short-term liquidity); Debt-to-equity of 1.52; Free cash flow per share is positive (1.67); Most recent quarter missed estimates by 20.7%; 2 consecutive earnings misses; EPS growth accelerating (-38.8% -> -7.3% QoQ); Analyst estimates rising over recent quarters
Get the Full AROC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →